Answers are grounded in this paper and cite their sources.
OBJECTIVE: To evaluate the adverse events and complications associated with focused ultrasound ablation surgery(FUAS)for benign uterine diseases in teaching and training centers. MATERIALS AND METHODS: From October 2010 to December 2023, 26,844 patients with benign uterine diseases were treated with FUAS and more than 2000 doctors had been trained in three teaching and training centers. Among the treated patients, 16,619 had uterine fibroids, 8732 had adenomyosis, 1154 had cesarean scar pregnancy, and 379 had placental accreta spectrum. According to the classification system of the Society of Interventional Radiology (SIR), these adverse events were classified as mild adverse event (no therapy or nominal therapy), moderate adverse event (moderate escalation of care, requiring substantial treatment), severe adverse event (marked escalation of care), Life-threatening or disabling event, and patient death or unexpected pregnancy abortion. From 2010 to 2023, the annual incidence rates of severe adverse events were 0%, 0.42%, 0%, 0%, 0.28%, 0.23%, 0.09%, 0.08%, 0.20%, 0.28%, 0.44%, 0.16%, 0.16%, and 0.10%, respectively. CONCLUSION: Based on the results, we concluded that FUAS is a safe treatment for benign uterine diseases. The training course for trainee did not increase the risk of severe adverse events.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: